Fractyl Health financials
$0.5200+10.40%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3.0K | $14.0K | $43.0K | $33.0K |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3.0K | $7.0K | $19.0K | $14.0K |
| Gross margin | — | — | — | — | — | — | 100.0% | 50.0% | 44.2% | 42.4% |
| Operating income | -$19.1M | -$20.8M | -$23.3M | -$22.7M | -$26.1M | -$24.8M | -$25.2M | -$23.8M | -$23.0M | -$21.5M |
| Net income | -$25.5M | $9.2M | -$43.7M | -$45.6M | -$27.9M | -$23.7M | -$25.0M | -$23.2M | -$17.2M | -$5.1M |
| Net margin | — | — | — | — | — | — | −832333.3% | −165521.4% | −40067.4% | −15330.3% |
| Diluted EPS | $-0.16 | $0.06 | $-0.31 | $-0.71 | $-0.57 | $-0.49 | $-0.51 | $-0.48 | $-0.36 | $-0.17 |
| EBITDA | -$18.8M | -$20.5M | -$23.0M | -$22.4M | -$25.8M | -$24.5M | -$25.0M | -$23.6M | -$22.8M | -$21.5M |
| Operating cash flow | -$15.9M | -$22.5M | -$21.3M | -$22.7M | -$21.2M | -$25.1M | -$17.0M | -$18.0M | -$18.7M | -$11.7M |
| Free cash flow | -$15.9M | -$22.5M | -$21.3M | -$22.7M | -$21.3M | -$25.5M | -$17.3M | -$18.3M | -$19.0M | -$12.8M |
| Diluted shares | 158.6M | 158.5M | 140.7M | 64.7M | 49.0M | 48.9M | 48.6M | 48.0M | 47.9M | 29.7M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $47.1M | $63.2M | $81.5M | $77.7M | $22.3M | $42.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $30.4M | $30.1M | $30.6M | $30.8M | $30.0M | $29.4M |
| Total assets | $82.0M | $99.4M | $121.4M | $114.3M | $62.0M | $83.0M |
| Total liabilities | $83.6M | $78.0M | $111.9M | $117.5M | $80.2M | $76.7M |
| Shareholders' equity | -$1.7M | $21.4M | $9.5M | -$3.2M | -$18.2M | $6.4M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology